Carroll Jill
Insider CIK 1598542 · AGTC Director, 10% owner · AVLN Director · ACLX Director · PAND Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVLN Avalyn Pharma Inc. | C Conversion deriv | 2026-05-01 | 2026-05-01 | 9,418,561 | — | $0 | 0 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion deriv | 2026-05-01 | 2026-05-01 | 27,309,719 | — | $0 | 0 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion | 2026-05-01 | 2026-05-01 | 1,419,298 | — | $0 | 1,419,298 | SEC↗ |
| AVLN Avalyn Pharma Inc. | C Conversion | 2026-05-01 | 2026-05-01 | 489,486 | — | $0 | 1,908,784 | SEC↗ |
| AVLN Avalyn Pharma Inc. | P Buy | 2026-05-01 | 2026-05-01 | 277,778 | $18.00 | $5.00M | 2,186,562 | SEC↗ |
| ACLX Arcellx, Inc. | D To issuer deriv | 2026-04-28 | 2026-04-28 | 9,174 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | D To issuer deriv | 2026-04-28 | 2026-04-28 | 8,011 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | D To issuer deriv | 2026-04-28 | 2026-04-28 | 11,459 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | U Tender | 2026-04-28 | 2026-04-28 | 1,479,148 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | A Award deriv | 2025-05-29 | 2025-05-30 | 9,174 | — | $0 | 9,174 | SEC↗ |
| ACLX Arcellx, Inc. | A Award deriv | 2024-05-28 | 2024-06-06 | 8,011 | — | $0 | 8,011 | SEC↗ |
| ACLX Arcellx, Inc. | S Sale | 2024-03-21 | 2024-03-25 | 504,263 | $70.55 | $35.58M | 1,479,148 | SEC↗ |
| ACLX Arcellx, Inc. | S Sale | 2023-12-14 | 2023-12-18 | 504,263 | $49.13 | $24.77M | 1,983,411 | SEC↗ |
| ACLX Arcellx, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 11,459 | — | $0 | 11,459 | SEC↗ |
| ACLX Arcellx, Inc. | S Sale | 2023-06-01 | 2023-06-02 | 25,556 | $44.35 | $1.13M | 2,487,674 | SEC↗ |
| ACLX Arcellx, Inc. | S Sale | 2023-05-31 | 2023-06-02 | 315,164 | $41.50 | $13.08M | 2,513,230 | SEC↗ |
| ACLX Arcellx, Inc. | S Sale | 2023-05-11 | 2023-05-15 | 6,485 | $46.15 | $299.3K | 2,828,394 | SEC↗ |
| ACLX Arcellx, Inc. | S Sale | 2023-05-11 | 2023-05-15 | 631,932 | $45.00 | $28.44M | 2,834,879 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion deriv | 2022-02-08 | 2022-02-09 | 1,550,309 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion deriv | 2022-02-08 | 2022-02-09 | 533,389 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion deriv | 2022-02-08 | 2022-02-09 | 666,651 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion deriv | 2022-02-08 | 2022-02-09 | 649,795 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion deriv | 2022-02-08 | 2022-02-09 | 433,196 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | P Buy | 2022-02-08 | 2022-02-09 | 66,667 | $15.00 | $1.00M | 3,466,811 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion | 2022-02-08 | 2022-02-09 | 3,400,144 | — | $0 | 3,400,144 | SEC↗ |
| ACLX Arcellx, Inc. | P Buy | 2022-02-08 | 2022-02-09 | 1,600,000 | $15.00 | $24.00M | 2,033,196 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion | 2022-02-08 | 2022-02-09 | 433,196 | — | $0 | 433,196 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | D To issuer deriv | 2021-04-01 | 2021-04-01 | 13,997 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | U Tender | 2021-04-01 | 2021-04-01 | 5,674,221 | $60.00 | $340.45M | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 1,776,980 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 7,846,554 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 361,111 | $18.00 | $6.50M | 2,248,304 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 348,469 | — | $0 | 1,887,193 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 1,538,724 | — | $0 | 1,538,724 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | A Award deriv | 2020-07-17 | 2020-07-21 | 13,997 | — | $0 | 13,997 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 32,707,070 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 17,625,289 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 15,671,969 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion | 2014-04-01 | 2014-04-01 | 1,885,836 | — | $0 | 1,885,836 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | P Buy | 2014-04-01 | 2014-04-01 | 103,762 | $12.00 | $1.25M | 1,989,598 | SEC↗ |